Clinical Trials in Austin

Showing 2201-2220 of 7,312 trials

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

NCT06620627

The PROCEED-CRC study will prospectively collect blood samples from participants who are at average risk of colorectal cancer (CRC). Samples will be used for research use and the development of a blood-based CRC screening test.

Colorectal Cancer Screening

Natera, Inc.5,000 participantsStarted Jan 2024

Austin, Texas, United States

Active Not RecruitingPhase 3< 1 mile

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT05348577

This study will assess the efficacy and safety of capivasertib plus docetaxel versus placebo plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the docetaxel with steroid therapy and receive androgen deprivation therapy. The intention of the study is to demonstrate that the combination of capivasertib plus docetaxel is superior to placebo plus docetaxel with respect to the overall survival and/or the radiographic progression free survival of study participants.

Prostate Cancer

AstraZeneca1,035 participantsStarted Mar 2022

Yuma, Arizona, United States • Beverly Hills, California, United States • Cerritos, California, United States +214 more locations

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection

Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)

Find Trials by Condition in Austin

Intermediate-Size Expanded Access Protocol (EAP) for LP352

CLUSTER Trial for Outbreak Detection and Response

Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

Study of Nerve Repair and Reconstruction Associated With Major Extremity Trauma

Safety and Clinical Activity of KT-253 in Adult Patients with High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors

A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

Novel Experimental COVID-19 Therapies Affecting Host Response

Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Non-Complex Biliary Stones DSC vs ERC

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)